A study by Nasution and colleagues showed that treatment with CAPE reduces AQP4 mRNA expression in the brain and AQP4 protein levels in the blood, suggesting this as a mechanism of action of CAPE in alleviating brain edema [133]. The gene discussed is AQP4; the disease is brain edema.